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Abstract
Cystatins are a family of inhibitors of cysteine peptidases that comprises the salivary cystatins (D and S-type cystatins) and
cystatin C. These cystatins are encoded by a multigene family (CST3, CST5, CST4, CST1 and CST2) organized in tandem in the
human genome. Their presence and functional importance in human saliva has been reported, however the distribution of
these proteins in other mammals is still unclear. Here, we performed a proteomic analysis of the saliva of several mammals
and studied the evolution of this multigene family. The proteomic analysis detected S-type cystatins (S, SA, and SN) in
human saliva and cystatin D in rat saliva. The evolutionary analysis showed that the cystatin C encoding gene is present in
species of the most representative mammalian groups, i.e. Artiodactyla, Rodentia, Lagomorpha, Carnivora and Primates. On
the other hand, D and S-type cystatins are mainly retrieved from Primates, and especially the evolution of S-type cystatins
seems to be a dynamic process as seen in Pongo abelii genome where several copies of CST1-like gene (cystatin SN) were
found. In Rodents, a group of cystatins previously identified as D and S has also evolved. Despite the high divergence of the
amino acid sequence, their position in the phylogenetic tree and their genome organization suggests a common origin with
those of the Primates. These results suggest that the D and S type cystatins have emerged before the mammalian radiation
and were retained only in Primates and Rodents. Although the mechanisms driving the evolution of cystatins are unknown,
it seems to be a dynamic process with several gene duplications evolving according to the birth-and-death model of
evolution. The factors that led to the appearance of a group of saliva-specific cystatins in Primates and its rapid evolution
remain undetermined, but may be associated with an adaptive advantage.
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Introduction
Saliva is an important body fluid that plays several roles in the
oral cavity, participating in processes such as lubrication, digestion
and protection of oral cavity [1–3]. In addition, saliva comprises
the first line of defence of the oral cavity [1,4]. Among the
components responsible for this role there are several peptides,
including cystatins. Cystatins belong to a superfamily of low
molecular weight proteins that are involved in the inhibition of
cysteine peptidases (CPs), such as mammalian cathepsins B, H and
L [5–7]. Four main cystatin families are known: type-I cystatins or
stefins; type-II cystatins; type-III cystatins or kininogens, and type-
IV cystatins, or fetuins [8].
Cystatin C, D and S-type (S, SN and SA) are type-II cystatins
composed by 120–125 amino acid residues containing two
disulfide bonds. In humans, these cystatins are encoded by the
genes CST3, CST5, CST4, CST1 and CST2, respectively, which
are located in tandem on chromosome 20 (20p11.21) [3,8,9].
Although cystatins C and D are frequently found in other body
fluids, S-type cystatins are saliva-specific and share a high degree
of amino acid similarity (,88%) [8]. S-type cystatins act as
cysteine-protease inhibitors, but they have also a small role in the
regulation of salivary calcium and present antimicrobial activity
[2,8,10,11]. Not all type-II cystatins show the same activity, i.e. D
and S-type cystatins are poorer inhibitors of cathepsins when
compared to cystatin C while cystatin C is less effective in the
bactericidal activity than cystatin S [8,10,12]. Additionally, human
cystatin S presents high affinity to the tooth surface, which suggests
a main role in the maintenance of the mineralized surfaces [8].
Indeed, there is a correlation between the activity of each cystatin
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and their evolution, with salivary cystatins becoming progressively
less active against the host lysosomal cathepsins B, H, and L [8].
Multigene families arise by gene duplication and this is a useful
mechanism to provide several copies of the same gene, and thus
increase gene expression [13]. However, the copies might face
pseudogenization, neofunctionalization and subfunctionalization
[14]. Pseudogenization generally occurs when the copies present
functional redundancy which frequently leads to the inactivation
of one of the copies by accumulation of deleterious mutations and
ultimately to the deletion from the genome [15]. In neofunctio-
nalization both copies are maintained in the genome as new
functions are acquired by one of the copies [16,17]. In
subfunctionalization there is a division of the ancestral functions
between the two copies [18]. Furthermore, species-specific gene
duplication might give rise to species-specific gene functions,
contributing to species divergence and adaptation [13,15].
For a long time it was generally accepted that evolution of
multigene families was associated with processes of genetic
exchange, such as gene conversion and unequal crossing-over
that homogenize the sequences [19,20]. This model of evolution
was designated concerted evolution. The birth-and-death model of
evolution [21–23] was later proposed to explain the pattern
observed in the evolution of the immunoglobulins heavy chain
variable region (IGHV), being quite similar to the accordion model
proposed by Klein et al. [24] to explain the MHC evolution. The
birth-and-death model of evolution suggests that during genome
evolution, genes can either duplicate and be maintained very
similar, diverge functionally or become pseudogenes. The end
result of this process is a mixture of both divergent and highly
homologous group of genes.
Previous evolutionary studies on this superfamily suggested that
from the type-II cystatins here in study, cystatin C is the most
ancestral, being found in several vertebrates. By duplication,
cystatin C originated the ancestor of the subfamily of salivary
cystatins (cystatin D, S, SA and SN) [8,25,26]. Several studies
indicate that cystatin C had its origin in an ancestral cystatin at
,650 million years ago (mya) during the evolution of bony
vertebrates, while D and S-type cystatins have a more recent
origin [8,25–27]. Some authors argue that D and S-type cystatins
evolved in Primates to protect the oral cavity from dietary and
environmental CPs as they present poor inhibition for endogenous
CPs [8]. However, some non-primate species have proteins also
assigned as D or S-type cystatins, which does not make clear if the
divergence of this specific group of cystatins occurred before or
after the mammalian radiation. Furthermore, the evolution of
these proteins in Primates is also not clear, making essential the
understanding of their evolution to better interpret their function
in the oral cavity. Here, we used a proteomic approach to assess
the presence of these proteins in the saliva of several mammal
species and conducted evolutionary analysis to determine their
origin and shed light into their evolutionary history.
Materials and Methods
Samples
Dog (Canis lupus, mongrel breed), horse (Equus cabalus), cow
(Bos taurus), sheep (Ovis aries) and human (Homo sapiens) saliva
samples were collected during 4 minutes using salivettes (Sterile
Saliva Collection Devices by Sarstedt) which were then centrifuged
at 10006g for 2 min to recover the saliva sample. For saliva
collection in rat (Rattus novergicus, strain Wistar) and European
rabbit (Oryctolagus cuniculus, domestic breed White New
Zealand), the animals were first injected with the sialagogue
pilocarpine (4 mmol/kg). All the samples were then centrifuged at
120006g for 10 min at 4uC to collect the supernatant.
Ethics statements
Human and animal saliva samples were collected using non-
invasive methods and without provoking suffering. None of the
animals included in this study was sacrificed and the fundamental
ethical principles including human rights and animal welfare
requirements at the national, regional and local regulations and
directives were respected. Human volunteer donors gave their
written informed consent after being informed of the research
project’s nature and that the Declaration of Helsinki was
respected. The ethics committee of Universidade de Tra´s-os-
Montes e Alto Douro (UTAD), Portugal, that approved the
human and animal studies was composed by Maria da Conceic¸a˜o
Azevedo, Jose´ Luı´s Correia Ribeiro, Maria Jose´ Gomes and Pedro
M. Mestre A. Silva. The animal studies were performed in the
Departamento de Cieˆncias Veterina´rias, CECAV, Universidade
de Tra´s-os-Montes e Alto Douro, Vila Real, Portugal.
Proteomic analysis
Proteins present in saliva samples were separated by gel
electrophoresis under denaturing conditions according to Laemmli
[28]. For mass spectrometry analysis, protein bands located
around the 15 kDa area were excised and were prepared
according to the conditions reported elsewhere [29]. Mass spectra
were obtained according to the conditions described by Vitorino et
al. [29].
MS/MS data was searched against the Swissprot and NCBI
protein databases for all species using paragon algorithm from
ProteinPilot software (version 4.0, Applied Biosystems, USA) and
Mascot software (v.2.1.0.4, Matrix Science Ltd, U.K.). An MS
tolerance of 30 ppm was selected for precursor ions and 0.3 Da for
fragment ions. Confidence levels $99% were used as positive
protein identification criteria. In order to estimate the false
discovery rate (FDR) a reverse decoy database was created for all
SwissProt resulting in 5% of FDR [false positive peptides/(false
positive peptides + total peptides)]*100. Unique peptides retrieved
from FDR search were considered for analysis.
Evolutionary analysis
Mammalian cystatins C, D, S, SA and SN nucleotide coding
sequences were obtained from NCBI (http://www.ncbi.nlm.nih.
gov) and Ensembl (http://www.ensembl.org) databases. Only
coding and complete sequences were considered. Accession
numbers for all retrieved sequences are presented in table S1.
Multiple sequence alignments were performed in BioEdit
Sequence Alignment Editor [30] using ClustalW [31] followed
by manual correction. Gallus gallus CST3 and Columba livia
CST-like sequences were included as outgroup. To assess the fit of
our dataset to 88 models of nucleotide evolution, the jModelTest
v2.1.1 [32] was used considering the Akaike information criterion
(AIC). Evolutionary relationships between the type-II cystatins
were analysed in Maximum Likelihood (ML) and Bayesian
inference (BI) frameworks. ML analyses were performed using
PhyML v3.0 [33] specifying TPM3+I+G as the best fitting
mutation model. The support of the resulting nodes was estimated
using 1000 bootstrap replicates as implemented in PhyML. BI
analyses were performed using MrBayes version 3.1.2 [34,35],
using a general time reversible (GTR) model of nucleotide
substitutions with invariant gamma distribution (4 categories).
Markov Chain Monte Carlo (MCMC) chains run for 26106
generations, sampling every 1000 generations, with the first
200000 sampled trees discarded. Convergence was checked using
Evolution of C, D and S-Type Cystatins in Mammals
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Tracer v1.5 [36] and the tree was visualized with FigTree v1.4.0
(http://tree.bio.ed.ac.uk/software/figtree/).
To evaluate the selective pressures on the CST3 gene, five
methods available in the DATAMONKEY web server [37] were
used: SLAC, FEL, REL, MEME and FUBAR. For these analyses,
the best fitting nucleotide substitution model was determined
through the automatic model selection tool available on the server.
For SLAC, FEL and MEME the P-values were set into 0.05; for
REL, a P-value of 100 was used and for FUBAR a P-value of 0.95.
Results
Proteomic analysis
Characterization of the saliva from different mammal species by
a proteomic approach did not allow the identification of cystatin C
in any of the species studied. S-type cystatins (S, SA and SN) were
only found in human saliva and cystatin D was identified only in
rat saliva (Table 1).
Evolutionary analysis
The sequences of the genes encoding C, D and S-type cystatins
(CST3, CST5, CST4, CST1 and CST2) retrieved from the public
databases showed that cystatin C had already been annotated in
several mammal species while the sequences assigned as D and S-
type cystatins were almost exclusive to Primates. However, in some
cases, the available sequences were incorrectly annotated or barely
assembled.
In humans, the genomic location of the genes encoding these
proteins is well characterized. Indeed, they are located in tandem
on chromosome 20 in the locus p11.21. In other mammal species,
we observed that the locus containing these genes is often located
in a syntenic region, being flanked by the NXT1 and GZF1 genes
at the 59 end and the ACSS1 gene at the 39 end (Figure 1). In dog
genome, the syntenic region is not conserved since this region
seems to have been split into chromosomes 23 and 24. However,
cystatin genes appear in the same order as observed in the other
mammals’ genomes. Along with the CST1-5 genes, other type-II
cystatin genes locate to this syntenic region, including CSTL1,
CST11, CST8, CST9L, CST9 and CST7 (Figure 1).
CST3 is the only gene present in all the mammalian orders
included in this study while the remaining analysed genes, CST1,
CST2, CST4 and CST5, are present mostly in Primate genomes.
On the human genome the five studied genes are arranged as
follows: CST3-CST4-CST1-CST2-CST5, spanning ,200 kb at
approximate equal distance (Figure 1). A similar organization was
also observed in the Pan troglodytes genome, despite the lack of
CST5, and in the Gorilla gorilla genome, despite the lack of CST3
and CST2 genes. Multiple copies of a CST1-like gene have been
annotated in the Pongo abelii genome; all, but CST1-like (3)
(XM_002834995) for which the chromosomal location remains
unknown, locate on chromosome 20 at random positions.
In the Macaca mulatta cystatin locus, located on chromosome
10 (and not chromosome 20 as for Humans and Apes), the CST1/
CST2 gene (annotated as CST1 in ENSEMBL and as CST2 in
NCBI) is located in an unusual position within CST9 and CST3
genes; in addition, downstream of the CST5 gene, where S-type
cystatins genes were expected to be located, more than one copy of
the CST9L gene is found. Moreover, the CST1/CST2 gene and
the CST9L genes present a different genome transcriptional
orientation from that of their orthologues.
In Rattus norvegicus, downstream to the CST3 gene, four
coding genes are annotated as S or S-like cystatins followed by one
gene assigned as CST5. This chromosomal organization is similar,
but not entirely consistent with that observed in Primates. In the
remaining mammals, representing the Artiodactyla (Bos taurus
and Sus scrofa) and Carnivora (Canis lupus) orders, only the
CST3 gene could be identified.
The alignment of the amino acid sequences of C, D and S-type
cystatins allowed the detection of amino acid motifs that could be
relevant to their functional role (Figure 2). For cystatins, three
motifs that are important for the inhibition of cysteine peptidases
(CPs) have been described: one N-terminal G residue and the
QXVXG and PW motifs [8]; these were observed in almost every
cystatin sequence retrieved (Figure 2). Moreover, by looking at the
amino acid sequences, the different cystatins present specific
amino acid motifs that allow their distinction (Figure 2). However,
the S-type cystatins, S, SA and SN, share several amino acid
substitutions that hamper their assignment as different types. From
the amino acid alignment it was also noticeable that the rat
cystatin S is highly divergent, being substantially different from
their Primates’ counterparts. The tests for selective pressures for
cystatin C showed that only ,30% of randomly positioned codons
are under negative selection (Figure 2).
The ML and BI methodologies used to study the evolutionary
relationships between these type-II cystatins returned phylogenies
with similar topologies (Figure 3). Cystatin C encoding sequences
(CST3 gene) of representatives of several mammal orders are at a
basal position in the tree, within which the branching generally
agrees with the accepted mammalian phylogeny [38]. All the
Primates’ D and S-type cystatins and the Rodents’ cystatins are
grouped in a branch well supported by the Bayesian analysis (1.00
posterior probability). Primates’ cystatin D and S-type cystatins
(CST1, CST2 and CST4) form a poorly supported group
(posterior probability and bootstrap confidence under 0.95 and
Table 1. Cystatins found by LC-MS/MS from human, dog, sheep, cattle, horse, rabbit and rat saliva.
Cystatin SN Cystatin SA Cystatin S Cystatin D Cystatin C
Human CYTN_HUMAN gi|235948 CYTS_HUMAN - -
Dog - - - - -
Bovine - - - - -
Sheep - - - - -
Horse - - - - -
Rabbit - - - - -
Rat - - - gi|344250777 -
The searches that allowed these identifications were made using the Mascot software against the Swissprot and NCBI databases. The accession numbers/gi numbers are
indicated.
doi:10.1371/journal.pone.0109050.t001
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90%, respectively). Within the Primates’ cystatin D group,
sequences cluster in accordance to the Primates’ phylogeny [39].
As for S-type cystatins, this clustering is not clear, with the
relationships among S, SN and SA cystatins not well resolved.
Within the S-type group, the sequences of an S-like cystatin from
New World Monkeys (Platyrrhini) form a highly-supported group
(1.00 posterior probability, 99% bootstrap confidence). For
Catarrhini (Apes and Old World Monkeys), the branches
containing SA cystatins and S cystatins are well supported (1.00
posterior probability for both) and seem to have resulted from the
duplication of an ancestral gene. Albeit poorly supported, the five
copies of a CST1-like that are annotated in the Pongo abelii
genome (CST1-like(1) to CST1-like(5)), group in the cystatin SN
group indicating that these are CST1 genes. These copies do not
group together suggesting at least two major duplication events in
their origin. The Rodent sequences previously identified as D and
S cystatins and Cricetulus griseus C-like cystatin form a group
apart from all other D and S-type cystatins (1.00 posterior
probability; 68% bootstrap confidence), reflecting the high genetic
distances between these sequences and that of other Primates’
cystatins.
With this phylogenetic analysis some discrepancies in the
annotations of the different databases were detected. For example,
Macaca mulatta ENSEMBL CST1 sequence (EN-
SMMUT00000005570) matches the NCBI database CST2
sequence (XM_001097284). These conflicts in gene annotation
might result from the high similarity between S-type cystatins.
Discussion
Despite the importance of salivary cystatins in the protection of
the human oral cavity, they are regularly described as Primate
specific. The proteomic approach used in the analysis of rat, dog,
rabbit, sheep, horse, bovine and human saliva only revealed the
presence of cystatin D in rat saliva and S-type cystatins in human
saliva. None of the other type-II cystatins were found in these
species. However, presence of cystatin C in human saliva had been
previously confirmed [40], despite not being a major cystatin in
this fluid [41]. Since high salivary levels of cystatin C are mainly
Figure 1. Type-II cystatin gene cluster region overview. Organization of the CST1-5 genes in human (Homo sapiens), chimpanzee (Pan
troglodytes), orangutan (Pongo abelii), gorilla (Gorilla gorilla), rhesus monkey (Macaca mulatta), marmoset (Callithrix jacchus), rat (Rattus norvegicus),
mouse (Mus musculus), pig (Sus scrofa), cattle (Bos taurus) and dog (Canis lupus familiaris). The transcriptional orientation of the genes is shown; the
pseudogenes are highlighted in yellow (data from ENSEMBL and NCBI databases). The genes used in the subsequent analysis are highlighted in blue.
doi:10.1371/journal.pone.0109050.g001
Figure 2. Amino acid composition of cystatins. Homo sapiens cystatin C (P01034); Bos taurus cystatin C (P01035); Rattus norvegicus cystatin C
(P14841); Canis lupus familiaris cystatin C (J9NS29); Homo sapiens cystatin D (P28325); Callithrix jacchus cystatin D (ENSCJAP00000001156); Macaca
mulatta cystatin D (G7N352); Homo sapiens cystatin SN (P01037); Pan troglodytes cystatin SN (H2QK35); Homo sapiens cystatin S (P01036); Pan
troglodytes cystatin S (H2QK34); Homo sapiens cystatin SA (P09228); Pan troglodytes cystatin SA (H2QK36) and Rattus norvegicus cystatin S (P19313).
Filled grey boxes indicate conserved amino acid motifs; empty boxes indicate conserved amino acids characteristic of each cystatin; asterisks (*) mark
the codons on CST3 under negative selection.
doi:10.1371/journal.pone.0109050.g002
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associated with oral inflammatory processes [42], the presence of
low amounts of cystatin C can explain its non-detection by the
proteomic approach.
Sequences of the CST3 gene are present in almost all of the
analysed genomes, consistently located upstream of the CSTL1,
CST11, CST9L, CST9 and CST8 genes which are other type-II
Figure 3. Phylogenetic tree inferred by using Maximum Likelihood (ML) and Bayesian inference (BI). TPM3+I+G was the best fitting
mutation model. For ML 1000 bootstrap replicates were considered and for BI posterior probabilities were calculated; posterior probabilities (bold)
over 0.95 and bootstrap confidence (italic) over 90% are considered valid support and are shown in the tree.
doi:10.1371/journal.pone.0109050.g003
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cystatins genes also located in this cystatin locus (Figure 1). Besides
its location in a syntenic region, the retrieved cystatin C (CST3)
amino acid sequences showed that cystatin domains 55QXVXG59,
105PW106 and the N-terminal G11 [25] are highly conserved in
almost all sequences analysed (Figure 2). Thus, the absence of a
high degree of differentiation between cystatin C proteins in the
different mammal species may suggest an important role of this
protein in mammals that has been maintained in mammalian
evolution. In addition, all cystatin C sequences clustered in a well-
supported group in the phylogenetic tree and further grouped in
accordance to the accepted molecular tree of placental mammals,
clearly distinguishing branches for Primates, Lagomorphs, Ro-
dents, Carnivores and Artiodactyls (Figure 3), thus reflecting the
mammalian evolution [38]. This, and the basal position of these
sequences in the tree, support the previous hypothesis that CST3 is
the most ancestral gene among the genes here in study [8,26].
On the constructed ML and BI phylogenetic trees, the Primates’
cystatins D (CST5) appear on a single highly-supported cluster,
comprising sequences from Platyrrhini (New World Monkeys) and
Catarrhini (Old World Monkeys, Great Apes and Human),
suggesting that cystatin D originated in the ancestor of the
Simiiformes at ,36–50 mya [39]. Moreover, the phylogenetic
relationships between the CST5 sequences follow these species
accepted phylogeny [39].
The remaining genes, CST1, CST2 and CST4, which encode
type-S cystatins (SN, SA and S, respectively) were found in several
Primates’ genomes, but the high degree of similarity between them
might confound their identification. In the phylogenetic tree, these
sequences appear in a highly-supported branch (1.00 posterior
probability, 95% bootstrap confidence), which supports a common
origin for these Simiiformes’ S-type cystatins [39] (Figure 3), but
the branching within the S-type cystatins is not as well resolved.
The Platyrrhini (New World monkeys) cystatins are clustered in a
well-supported branch in a basal position. As for SA cystatins, its
presence is only confirmed in the Hominidae family. In this
branch, Pan paniscus CST4-like(1) groups with Homo sapiens
CST2, Pan troglodytes CST2 and Pongo abelli CST2, which
suggests an incorrect annotation of this sequence; due to its
similarity to other CST2 genes, this sequence is most likely of a
CST2 gene. The tree also presents a branch containing Old World
monkeys’ cystatins (Macaca mulatta CST1/CST2 and Papio
anubis CST4-like). The information from the chromosomal
location of the gene assigned as CST1/CST2 in Macaca mulatta
places it in an unusual region compared to that of the other S-type
cystatins (Figure 1); however the phenomenon that led to the
misconfiguration of this chromosomal region is unclear. Its
location in the tree, together with the Papio anubis CST4-like,
suggests that this branch represents the S-type cystatins in Old
World monkeys which has not suffered further duplications
(Figure 3).
According to our results, an ancestral S-like gene appeared in
the Simiiformes common ancestor and persisted in Platyrrhini
where no further duplication occurred. In Catarrhini, this
ancestral S-like gene gave rise to S-type Old World monkeys
cystatins and in Apes the ancestral gene evolved and duplicated
giving rise to CST1, CST2 and CST4 (Figure 4).
The evolution of S-type cystatins through duplication events in
Apes seems to be an ongoing process as observed from the Pongo
abelii genome where several sequences of cystatin SN (CST1-like
gene) were found. These Pongo abelii CST1-like(1–5) copies are
separated into two groups, one group is represented by CST1-
like(1) and (2), and the other contains CST1-like(3), (4) and (5); this
indicates an origin through at least two independent duplications.
However, further studies are necessary to determine whether all
CST1-like copies from Pongo abelii are equally transcribed. In
these duplicates, several amino acid substitutions occur in the two
characteristic cystatin conserved domains (data not shown), but it
is not clear if the observed mutations can interfere with the
cysteine protease inhibitor activity or if they involve the acquisition
of novel functions.
In Rodents, the phylogenetic position of the CST3-like gene in
Cricetulus griseus and the CST5 and CST4-like genes in Rattus
norvegicus, along with their genomic location which resembles the
gene organization observed in Primates (Figure 1), could imply a
common origin for these cystatins. Furthermore, the proteomic
analysis revealed that rat cystatin D is expressed in saliva, as for S-
type cystatins in Primates (Table 1). The rat cystatin S was
formerly identified as LM protein, being latter assigned to cystatin
S due to similarities of the amino acid sequence with other type-II
cystatins (Figure 2) and to its ability to inhibit some cysteine
proteases [43]. The Rodent cystatins retrieved present similar
functional domains to that of the type-II cystatins (http://prosite.
expasy.org/); nevertheless, while for human cystatin S its functions
are defined [8], these have not been determined for the Rodent
proteins. Thus, our results suggest that D and S like cystatin genes
emerged before the mammalian radiation but only persisted in
Primates and in Rodents.
Multigene families are the result of gene duplication and
according to the birth-and-death evolution model some of the
copies might remain similar, some might diverge functionally and
others might become pseudogenes [18]. Evolution of cystatins
seems to follow this model with many proteins presenting similar
structure and function. A few pseudogenes have been identified
[44] (Figure1), but some novel functions such as antiviral and
antibacterial activities have also been attributed to some members,
which might explain their persistence [8]. The factors that lead to
the appearance of a group of saliva-specific cystatins in Primates
and its rapid evolution remain undetermined, but might be
associated with an adaptive advantage.
Figure 4. Diagram of salivary cystatin evolution. Cystatin genes estimated emergence is shown (divergence times were based on [45]).
doi:10.1371/journal.pone.0109050.g004
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Conclusions
Salivary cystatins (D and S-type cystatins) play a crucial role in
human saliva for homeostasis of the oral cavity. The main function
of this protein family is the inhibition of CPs, but new roles, such
as antimicrobial activity, have been detected. This neofunctiona-
lization might explain the maintenance of a high number of copies
for some of these genes in some species. In human saliva these
cystatins can be found, but screening the saliva from other
mammalian species showed that cystatin D was found only in rat
saliva while none of the other salivary cystatins were present.
Although the mechanisms that lead to the evolution of cystatins
are unknown, Primates’ cystatins compose a distinct group that
arose by several rounds of duplication with the proteins most likely
acquiring new functions. In particular for S-type cystatins, their
high similarity and the lack of specific characteristics that allow
their distinction frequently lead to their misannotation in the
databases. In Rodents, a group of cystatins has also evolved with
similar genomic location and conserved domains when comparing
to the Primates’ D and S-type cystatins; its location in the
phylogenetic tree suggests a common origin. These results show
that these genes were present in the genome before the
mammalian radiation.
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